Tomas Eriksson
Tomas Eriksson
CEO

CEO since June 2008.
Employed since June 2008.
Born: 1964
Education and experience: Tomas Eriksson has a bachelor degree from Lund University, specialising in business administration, and has worked as a business developer and project manager with particular focus on early development life science companies. He also has extensive experience from leading positions in the field of medical technology and diagnostics, including: Area Manager at Gambro AB, Sales Manager at Nordic Bioscience (Denmark), and Sales & Marketing Director at Magle Life Science AB.
Other assignments: Tomas Eriksson is chairman of the board at Finja Founders AB and Merozyne Therapeutics AB, and a board member at Enorama Pharma AB, Finja Five AB, and Kombinator Affärsutveckling AB. Tomas is CEO of the Company’s subsidiary, Preelumina Diagnostics AB. He also owns Kombinator O.B. and Kombinator Affärsutveckling AB, and is a partner in Finja Five AB (10 per cent) and Swede Unipharma AB (17 per cent).
Previous assignments in the last five years: Tomas Eriksson has previously been CEO of Lund University Bioscience AB, a board member at WC Likvid AB and Ximmune AB, and chairman of the board at Termino C 243 AB.
Holding: 84,515 shares in the Company, directly and through a wholly-owned company. Tomas Eriksson also holds 18,859 warrants 2015/2018.
 
Eddie Thordarson
Eddie Thordarson
Head of Development

Head of Development since November 2015.
Employed since November 2015.
Born: 1969
Education and experience: PhD in Chemistry from Lund University. Eddie Thordarson has had his own company within development and production of advanced technical equipment for analysis, and for the past 15 years has worked in development, marketing and management at a number of companies. Eddie joined A1M Pharma from the position of CEO at Magle AB, which develops medtech products for, among other areas, surgical hemostasis and interventional radiology. During this period he also had a board assignment at Nicachet AB.
Other assignments: Eddie Thordarson owns Eddie Thordarson Holding AB.
Previous assignments in the last five years: Eddie Thordarson has previously been CEO at Magle AB. Eddie has been a deputy board member at DCG Nordic AB. He has had no completed partnerships over five per cent in the last five years.
Holding: 18,000 shares and 12,572 warrants 2015/2018.
 
Fredrik Werner
Fredrik Werner 
CFO

CFO since Mars 2018.
Born: 1966
Education and experience: Bachelor degree specialising in business administration. Fredrik Werner has long experience from leading positions in life science. Previous roles include CEO of Airsonett AB, CFO at BoneSupport AB and Management Consultant at PwC.
Other assignments: Consultancy within FOC Venture.
Previous assignments in the last five years: CEO at Airsonett AB
Holding: 0 shares
 
A1M Pharma AB | Scheelevägen 22 | 223 63 Lund
+46 46 286 50 30 | info@a1m.se
Member of Preeclampsia Foundation
Legal disclaimer | © Copyright - A1M